These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30093951)

  • 1. Emerging role of C5a/C5aR IL-17A axis in cGVHD.
    Chen X; Lai P; Wang Y; He C; Wu S; Huang X; Geng S; Luo C; Ling W; Zeng L; Li P; Jiang Z; Weng J; Du X
    Am J Transl Res; 2018; 10(7):2148-2157. PubMed ID: 30093951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg.
    Wang Y; Lai P; Chen X; He C; Huang X; Geng S; Luo C; Wu S; Ling W; Zhong L; Lu Z; Li P; Weng J; Du X
    Sci Rep; 2017 Jun; 7(1):3603. PubMed ID: 28620195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.
    Pawaria S; Ramani K; Maers K; Liu Y; Kane LP; Levesque MC; Biswas PS
    J Immunol; 2014 Oct; 193(7):3288-95. PubMed ID: 25149466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4
    Hu X; Li X; Hu C; Qin L; He R; Luo L; Tang W; Feng J
    Sci Rep; 2017 Nov; 7(1):15207. PubMed ID: 29123203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of C5a on IL-17A, IL-17F, and IL-23.
    Grailer JJ; Bosmann M; Ward PA
    Front Immunol; 2012; 3():387. PubMed ID: 23316190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.
    Eglite S; Plüss K; Dahinden CA
    J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD.
    Lai P; Chen X; Guo L; Wang Y; Liu X; Liu Y; Zhou T; Huang T; Geng S; Luo C; Huang X; Wu S; Ling W; Du X; He C; Weng J
    J Hematol Oncol; 2018 Dec; 11(1):135. PubMed ID: 30526632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.
    Yoneda M; Imamura R; Nitta H; Taniguchi K; Saito F; Kikuchi K; Ogi H; Tanaka T; Katabuchi H; Nakayama H; Imamura T
    Oncol Lett; 2019 Jan; 17(1):913-920. PubMed ID: 30655847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.
    Syed SN; Rau E; Ziegelmann M; Sogkas G; Brüne B; Schmidt RE
    Eur J Immunol; 2018 Apr; 48(4):696-704. PubMed ID: 29277896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice.
    Li L; Xiong ZY; Qian ZM; Zhao TZ; Feng H; Hu S; Hu R; Ke Y; Lin J
    Neurobiol Dis; 2014 Jun; 66():74-82. PubMed ID: 24607885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation.
    Zhao XY; Lv M; Xu LL; Qian X; Huang XJ
    Eur J Immunol; 2013 Mar; 43(3):838-50. PubMed ID: 23280509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
    Liu Y; Xu SQ; Long WJ; Zhang XY; Lu HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7994-8003. PubMed ID: 30536348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
    Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of C5a-C5aR axis in the development of atherosclerosis.
    An G; Ren G; An F; Zhang C
    Sci China Life Sci; 2014 Aug; 57(8):790-4. PubMed ID: 25104451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
    Lee H; Whitfeld PL; Mackay CR
    Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 genetic and immunophenotypic evaluation in chronic graft-versus-host disease.
    Resende RG; Correia-Silva Jde F; Silva TA; Salomão UE; Marques-Silva L; Vieira ÉL; Dutra WO; Gomez RS
    Mediators Inflamm; 2014; 2014():571231. PubMed ID: 25136146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.
    Forcade E; Paz K; Flynn R; Griesenauer B; Amet T; Li W; Liu L; Bakoyannis G; Jiang D; Chu HW; Lobera M; Yang J; Wilkes DS; Du J; Gartlan K; Hill GR; MacDonald KP; Espada EL; Blanco P; Serody JS; Koreth J; Cutler CS; Antin JH; Soiffer RJ; Ritz J; Paczesny S; Blazar BR
    JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.